FDx Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
+789
| New | +$204K | 0.06% | 176 |
|
|
2023
Q3 | – | Sell |
-1,986
| Closed | -$434K | – | 751 |
|
|
2023
Q2 | $434K | Sell |
1,986
-2,471
| -55% | -$540K | 0.02% | 488 |
|
|
2023
Q1 | $928K | Hold |
4,457
| – | – | 0.04% | 315 |
|
|
2022
Q4 | $928K | Buy |
4,457
+105
| +2% | +$21.9K | 0.04% | 315 |
|
|
2022
Q3 | $950K | Sell |
4,352
-1,393
| -24% | -$304K | 0.04% | 290 |
|
|
2022
Q2 | $1.2M | Sell |
5,745
-85
| -1% | -$17.8K | 0.05% | 288 |
|
|
2022
Q1 | $1.41M | Buy |
5,830
+198
| +4% | +$48K | 0.05% | 262 |
|
|
2021
Q4 | $1.47M | Sell |
5,632
-284
| -5% | -$74K | 0.04% | 276 |
|
|
2021
Q3 | $1.56M | Buy |
5,916
+153
| +3% | +$40.3K | 0.05% | 255 |
|
|
2021
Q2 | $1.42M | Buy |
5,763
+482
| +9% | +$119K | 0.05% | 262 |
|
|
2021
Q1 | $1.03M | Buy |
5,281
+232
| +5% | +$45K | 0.04% | 288 |
|
|
2020
Q4 | $1.07M | Buy |
5,049
+236
| +5% | +$50.2K | 0.04% | 255 |
|
|
2020
Q3 | $825K | Buy |
4,813
+105
| +2% | +$18K | 0.04% | 268 |
|
|
2020
Q2 | $904K | Sell |
4,708
-1,476
| -24% | -$283K | 0.05% | 244 |
|
|
2020
Q1 | $911K | Sell |
6,184
-629
| -9% | -$92.7K | 0.06% | 206 |
|
|
2019
Q4 | $1.06M | Buy |
6,813
+179
| +3% | +$27.7K | 0.06% | 217 |
|
|
2019
Q3 | $896K | Buy |
6,634
+717
| +12% | +$96.8K | 0.06% | 234 |
|
|
2019
Q2 | $722K | Buy |
5,917
+278
| +5% | +$33.9K | 0.03% | 399 |
|
|
2019
Q1 | $586K | Buy |
5,639
+1,426
| +34% | +$148K | 0.02% | 432 |
|
|
2018
Q4 | $480K | Buy |
+4,213
| New | +$480K | 0.04% | 314 |
|